Inflation Reduction Act
Amgen’s Wezlana Emerges as Competitor to J&J’s Stelara, Shaping Medicare Negotiations
Johnson & Johnson may find a silver lining in the recent FDA approval of Amgen’s biosimilar for Stelara. This approval ...
Relay postpones its rare cancer drug approval plans due to IRA, losing ground to competitors
Relay Therapeutics is altering its strategic course, driven by the effects of the Inflation Reduction Act (IRA), leading the biotech ...
Novo Nordisk Opposes, Then Joins CMS Drug Pricing Program Amidst Industry Tensions
Novo Nordisk has become the latest player in the biopharmaceutical industry to challenge the drug price negotiation provisions outlined in ...
Big Pharma agrees to negotiate drug prices with Medicare: What does it mean for patients and taxpayers?
Following the recent disclosure by the Centers for Medicare & Medicaid Services (CMS) regarding the list of drugs slated for ...
Big Pharma’s stance on CMS drug price negotiations remains unclear
Following the release of the list of drugs slated for pricing negotiations under the Inflation Reduction Act (IRA) by the ...
Bristol Myers Squibb aims for 25+ new indications to overcome patent losses and pricing challenges
Bristol Myers Squibb is placing a significant bet on its robust pipeline to weather challenges such as the Inflation Reduction ...
Medicare Price Negotiations Could Slash Biotech R&D Spending, Gilead-Funded Study Warns
The Inflation Reduction Act (IRA) is projected to have a more significant impact on pharmaceutical research and development (R&D) than ...
Novartis sues U.S. government over IRA price negotiations for Entresto
Novartis has taken legal action against the U.S. government in response to the Inflation Reduction Act (IRA), becoming the latest ...
Bracing for Change: CMS Unveils Drug Price Negotiation Targets Amid Industry Backlash
The day that pharmaceutical manufacturers have been cautiously eyeing has finally dawned – Tuesday saw the grand revelation of the ...
Legal Skirmishes Erupt as AstraZeneca Delves into Battle Over Drug Pricing Reforms with IRA
As the clock ticks down to the eagerly awaited unveiling of the Centers for Medicare and Medicaid Services’ (CMS) list ...
Boehringer Ingelheim Enters Legal Fray Against Inflation Reduction Act, Citing Constitutional Concerns
The legal battle surrounding the Inflation Reduction Act (IRA) has intensified as pharmaceutical giant Boehringer Ingelheim joins the ranks of ...
AARP Backs Justice Department Against Chamber of Commerce’s Lawsuit on Medicare Drug Price Talks
A new development has emerged in the legal battle over the Inflation Reduction Act’s (IRA) provisions on prescription drug prices. ...
Department of Justice Criticises Chamber of Commerce’s Lawsuit Against IRA’s Medicare Price Negotiations
Exactly one year has passed since President Joe Biden’s signature inked the Inflation Reduction Act (IRA) into law. In a ...
Prescription Drug Cost Concerns Escalate to Shared ‘Core Value’ Across Party Lines, Survey Finds
Mounting worries over the soaring costs of prescription drugs have transcended political boundaries to become a deeply entrenched concern among ...
Johnson & Johnson is the fourth pharmaceutical company to sue the IRA over its medicine price negotiations
Johnson & Johnson has joined the wave of litigation by becoming the fourth major pharmaceutical company to sue the US ...
Merck increases its pressure on the IRA by requesting a ruling without a trial in its conflict with the US government
Merck is intensifying its fight against the drug price negotiation provisions in the Inflation Reduction Act (IRA) by requesting a ...
CMS introduces adjustments to Medicare price negotiation while maintaining a strong stance
The Centers for Medicare and Medicaid Services (CMS) has made some minor adjustments to its plan allowing Medicare to negotiate ...
